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Summary: The synthesis of 2,4-dimethoxypyrrolo[3,2-dlpyrimidine (4) is describ- 
e. d This facile, 3-step synthesis involves the brom&ation of 2,4zdimethoxy- 
6-methyl-5-nitropyrimidine (1) , and the subsequent conversion of compound 1 
into compound 4. 
A number of recent reports 
l-4 
have appeared on the synthesis of the pyrrolo- 
[3,2-dlpyrimidine ring system. This interest has been renewed by the finding 
that 9-deazaadenosine 14-amino-7-(6-D-ribofuranosyl)pyrrolo[3,2-d]pyrimidine] - - 
has demonstrated significant in vitro and in vivo antitumor activity 5,6 . 
Traditionally, the synthesis 7,8 of pyrrolo[3,2-dlpyrimidines which are 
unsubstituted at the six and seven positions has only been accomplished by the 
pyrolytic (300 'C, copper powder) decarboxylation of the corresponding 6-carboxy- 
pyrrolo[3,2-dlpyrimidine. Several additional methods starting from substituted 
pyrimidines' have produced pyrrolo[3,2-dlpyrimidines, however, the products of 
these reactions always contained either an alkyl, aryl or ethoxycarbonyl sub- 
stituent at the seven position. We now wish to report a facile, 3-step proce- 
dure for the synthesis of a novel 6,7_unsubstituted pyrrolo[3,2-dlpyrimidine (4). 
The procedure we have developed is simple and avoids the above mentioned 
decarboxylation which is too harsh for compounds which might contain sensitive 
groups such as a carbohydrate moiety. The synthesis of 2,4-dimethoxypyrrolo- 
[3,2-dlpyrimidine (S) was accomplished starting from 2,4-dimethoxy-5-nitro- 
pyrimidine' (1). Bromination of 1 with bromine (1.0 eq.] in refluxing glacial - 
acetic acid which contained sodium acetate (10 es.1 afforded a mixture of I-bro- 
momethyl-2,6-dimethoxy-5-nitropyrimidine (2_, 43%, yellow oil) and the dibromo- 
methyl derivative 2 (31%, m.p. 90-91 "C). After isolation by chromatography on 
4759 
4760 
silica gel (CH2C12 used as the elution solvent), pure 2 was reacted with excess - 













I-cyanomethyl-2,6-dimethoxy-5-nitropyrimidine (4, 55%, m.p. 75-77 "C). Com- 
pound 4 was then reductively ring closed by hydrogenation at 80 psig and 70 'C 
4761 
over 10% palladium on carbon. This reductive annulation appeared to follow the 
. . 
same course as has been reported" previously for the synthesis of substituted 
indoles from o-nitro-a-cyanotoluenes. Thus, not only was the nitro group readily - 
reduced to an amino group, but the cyano group was evidently also reduced to the 
corresponding imine which reacted with the ortho amino functionality to produce, 
after loss of ammonia, 2,4-dimethoxypyrrolo[3,2-dlpyrimidine" (2, 47%, 174- 
176 "C). The application of this facile synthesis of specific pyrrolo[3,2-cl.- 
pyrimidines in the area of general heterocyclic chemistry as well as the synthe- 
sis of C-nucleoside is under further investigation in our laboratory. 
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